產品詳情
簡單介紹：
Anti-CHMP4B+CHMP4C抗體產品質量穩定，實驗效果明顯，貨期快，價格優惠，歡迎垂詢訂購！我公司長期供應**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關試劑、熒光標記抗體、單克隆抗體、多克隆抗體、各種標記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-CHMP4B+CHMP4C抗體用于**組化實驗,WB實驗,相應的標記抗體有HRP標記抗體,FITC標記,BIO等。
詳情介紹：
Rabbit Anti-CHMP4B+CHMP4C
Cat. Number:
Anti-CHMP4B+CHMP4C抗體KL-7744R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
This gene encodes a member of the chromatin-modifying protein/charged multivesicular body protein (CHMP) protein family. TheAnti-CHMP4B+CHMP4C抗體 protein is part of the endosomal sorting complex required for transport (ESCRT) complex III (ESCRT-III), which functions in the sorting of endocytosed cell-surface receptors into multivesicular endosomes. The ESCRT machinery also functions in the final abscisson stage of cytokinesis and in the budding of enveloped viruses such as HIV-1. The three proteins of the CHMP4 subfamily interact with programmed cell death 6 interacting protein (PDCD6IP, also known as ALIX), which also functions in the ESCRT pathway. The CHMP4 proteins assemble into membrane-attached 5-nm filaments that form circular scaffolds and promote or stabilize outward budding. These polymers are proposed to help generate the luminal vesicles of multivesicular bodies. Mutations in this gene result in autosomal dominant posterior polar cataracts.[provided by RefSeq, Oct 2009].
Also known as:
SNF7 homolog associated withAnti-CHMP4B+CHMP4C抗體 Alix 3; C20orf178; Charged multivesicular body protein 4b; Charged multivesicular body protein 4c; CHMP 4B; CHMP 4C; CHMP4A; Chromatin modifying protein 4B; Chromatin modifying protein 4C; CTPP3; dJ553F4.4; hSnf7 2; hSnf7 3; hVps32; MGC22825; Shax1; Shax3; SNF7 2; SNF7 3; SNF7; Snf7 homologue associated with Alix 1; Vacuolar protein sorting associated protein 7 2; Vacuolar protein sorting associated protein 7 3.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Dog, Pig, Cow, Rabbit, .
●
Immunogen: KLH conjugated synthetic peptide derived from human CHMP4B/CHMP4C.
●
Predicted Molecular WeightAnti-CHMP4B+CHMP4C抗體: 25kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must Anti-CHMP4B+CHMP4C抗體be determined by the end user.
Not yet tested in other applications.
Optimal working dilutions must Anti-CHMP4B+CHMP4C抗體be determined by the end user.
kl384Hu01 端粒重復結合因子2(TERF2)多克隆抗體 Polyclonal Antibody to Telomeric Repeat Binding Factor 2 (TERF2)
kl386Hu01 二肽酶2(DPEP2)多克隆抗體 Polyclonal Antibody to Dipeptidase 2 (DPEP2)
kl390Mu02 雙腎上腺皮質**樣激酶1(DCLK1)多克隆抗體 Polyclonal Antibody to Doublecortin Like Kinase 1 (DCLK1)
kl396Mu01 脊椎蛋白2(SPON2)多克隆抗體 Polyclonal Antibody to Spondin 2 (SPON2)
kl396Mu02 脊椎蛋白2(SPON2)多克隆抗體 Polyclonal Antibody to Spondin 2 (SPON2)
kl419Mu01 硬脂酰輔酶A去飽和酶(SCD)多克隆抗體 Polyclonal Antibody to Stearoyl Coenzyme A Desaturase (SCD)
kl419Mu02 硬脂酰輔酶A去飽和酶(SCD)多克隆抗體 Polyclonal Antibody to Stearoyl Coenzyme A Desaturase (SCD)
kl419Ra01 硬脂酰輔酶A去飽和酶(SCD)多克隆抗體 Polyclonal Antibody to Stearoyl Coenzyme A Desaturase (SCD)
kl420Mu02 腓骨蛋白7(FBLN7)多克隆抗體 Polyclonal Antibody to Fibulin 7 (FBLN7)
kl422Mu01 衰老關鍵蛋白3(FBLN3)多克隆抗體 Polyclonal Antibody to Fibulin 3 (FBLN3)
kl422Mu02 衰老關鍵蛋白3(FBLN3)多克隆抗體 Polyclonal Antibody to Fibulin 3 (FBLN3)
kl435Hu01 F-框蛋白32(FBXO32)多克隆抗體 Polyclonal Antibody to F-Box Protein 32 (FBXO32)
kl453Hu01 纖連蛋白亮氨酸豐富跨膜蛋白3(FLRT3)多克隆抗體 Polyclonal Antibody to Fibronectin Leucine Rich Transmembrane Protein 3 (FLRT3)
kl458Hu01 含黃素單加氧酶1(FMO1)多克隆抗體 Polyclonal Antibody to Flavin Containing Monooxygenase 1 (FMO1)
kl460Mu01 葉酸受體1(FOLR1)多克隆抗體 Polyclonal Antibody to Folate Receptor 1, Adult (FOLR1)
kl460Mu02 葉酸受體1(FOLR1)多克隆抗體 Polyclonal Antibody to Folate Receptor 1, Adult (FOLR1)
kl507Ra01 驅動蛋白家族成員5B(KIF5B)多克隆抗體 Polyclonal Antibody to Kinesin Family, Member 5B (KIF5B)
kl515Hu01 驅動蛋白家族成員14(KIF14)多克隆抗體 Polyclonal Antibody to Kinesin Family, Member 14 (KIF14)
